tailieunhanh - Guanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer

Triple-negative breast cancer (TNBC) is characterized by a lack of estrogen and progesterone receptor expression (ESR and PGR, respectively) and an absence of human epithelial growth factor receptor (ERBB2) amplification. | Guanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN